| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | -0.071 | 0.1 |
| mRNA | WZ3105 | GDSC1000 | pan-cancer | AAC | 0.047 | 0.1 |
| mRNA | neopeltolide | CTRPv2 | pan-cancer | AAC | 0.11 | 0.1 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | 0.076 | 0.1 |
| mRNA | Sunitinib | FIMM | pan-cancer | AAC | 0.27 | 0.1 |
| mRNA | JW-55 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.1 |
| mRNA | GDC-0449 | GDSC1000 | pan-cancer | AAC | 0.056 | 0.1 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | -0.051 | 0.1 |
| mRNA | TAE684 | GDSC1000 | pan-cancer | AAC | 0.084 | 0.1 |
| mRNA | CAL-101 | GDSC1000 | pan-cancer | AAC | -0.05 | 0.1 |